Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918
In the original publication [...]
Saved in:
| Main Authors: | , , , , , , , , |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
MDPI AG
2024-11-01
|
| Series: | Pharmaceuticals |
| Subjects: | |
| Online Access: | https://www.mdpi.com/1424-8247/17/11/1533 |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
| _version_ | 1850068243587268608 |
|---|---|
| author | Medhat Taha Sara T. Elazab Alaa. M. Badawy Abdullah A. Saati Naeem F. Qusty Abdullah G. Al-Kushi Anas Sarhan Amira Osman Amira E. Farage |
| author_facet | Medhat Taha Sara T. Elazab Alaa. M. Badawy Abdullah A. Saati Naeem F. Qusty Abdullah G. Al-Kushi Anas Sarhan Amira Osman Amira E. Farage |
| author_sort | Medhat Taha |
| collection | DOAJ |
| description | In the original publication [...] |
| format | Article |
| id | doaj-art-7083b59adce046a1b15b97878a04e7eb |
| institution | DOAJ |
| issn | 1424-8247 |
| language | English |
| publishDate | 2024-11-01 |
| publisher | MDPI AG |
| record_format | Article |
| series | Pharmaceuticals |
| spelling | doaj-art-7083b59adce046a1b15b97878a04e7eb2025-08-20T02:48:07ZengMDPI AGPharmaceuticals1424-82472024-11-011711153310.3390/ph17111533Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918Medhat Taha0Sara T. Elazab1Alaa. M. Badawy2Abdullah A. Saati3Naeem F. Qusty4Abdullah G. Al-Kushi5Anas Sarhan6Amira Osman7Amira E. Farage8Department of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, EgyptDepartment of Pharmacology, Faculty of Veterinary Medicine, Mansoura University, Mansoura 35516, EgyptDepartment of Anatomy and Embryology, Faculty of Medicine, Mansoura University, Mansoura 35516, EgyptDepartment of Community Medicine and Pilgrims Healthcare, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi ArabiaMedical Laboratories Department, Faculty of Applied Medical Sciences, Umm Al-Qura University, Makkah 24382, Saudi ArabiaDepartment of Human Anatomy, Faculty of Medicine, Umm Al-Qura University, Makkah 24382, Saudi ArabiaDepartment of Internal Medicine, College of Medicine, Umm Al-Qura University, Makkah 24382, Saudi ArabiaDepartment of Histology, Faculty of Medicine, Kafrelsheikh University, Kafr Elsheikh 33511, EgyptDepartment of Anatomy and Embryology, Faculty of Medicine, Kafrelsheikh University, Kafr Elsheikh 33511, EgyptIn the original publication [...]https://www.mdpi.com/1424-8247/17/11/1533n/a |
| spellingShingle | Medhat Taha Sara T. Elazab Alaa. M. Badawy Abdullah A. Saati Naeem F. Qusty Abdullah G. Al-Kushi Anas Sarhan Amira Osman Amira E. Farage Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 Pharmaceuticals n/a |
| title | Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 |
| title_full | Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 |
| title_fullStr | Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 |
| title_full_unstemmed | Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 |
| title_short | Correction: Taha et al. Activation of SIRT-1 Pathway by Nanoceria Sheds Light on Its Ameliorative Effect on Doxorubicin-Induced Cognitive Impairment (Chemobrain): Restraining Its Neuroinflammation, Synaptic Dysplasticity and Apoptosis. <i>Pharmaceuticals</i> 2022, <i>15</i>, 918 |
| title_sort | correction taha et al activation of sirt 1 pathway by nanoceria sheds light on its ameliorative effect on doxorubicin induced cognitive impairment chemobrain restraining its neuroinflammation synaptic dysplasticity and apoptosis i pharmaceuticals i 2022 i 15 i 918 |
| topic | n/a |
| url | https://www.mdpi.com/1424-8247/17/11/1533 |
| work_keys_str_mv | AT medhattaha correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT saratelazab correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT alaambadawy correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT abdullahasaati correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT naeemfqusty correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT abdullahgalkushi correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT anassarhan correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT amiraosman correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 AT amiraefarage correctiontahaetalactivationofsirt1pathwaybynanoceriashedslightonitsameliorativeeffectondoxorubicininducedcognitiveimpairmentchemobrainrestrainingitsneuroinflammationsynapticdysplasticityandapoptosisipharmaceuticalsi2022i15i918 |